Literature DB >> 9307158

Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy.

D Xhrouet-Heinrichs1, K Lagrou, C Heinrichs, M Craen, L Dooms, P Malvaux, F Kanen, J P Bourguignon.   

Abstract

The aim of the present study was to evaluate the behavioral and affective characteristics and the changes in psychosocial functioning resulting from precocious puberty in 15 girls with central precocious puberty treated for 2 y using the GnRH agonist long-acting triptorelin, and in 5 untreated girls. After diagnosis of precocious puberty at 6.6-10.4 y of age, height, weight and pubertal development were evaluated at 3-month intervals over 2 y. Semi-structured interviews were carried out with the patient, the parents and the pediatric endocrinologists at 1, 8, 16 and 24 months after diagnosis. Standardized questionnaires (Child Behavior Checklist, Self-esteem Inventory) were administered at 1 and 24 months or 16 and 24 months, respectively. There was a mean 1.5-y delay between the observation of signs of puberty as reported by the parents and the diagnosis of precocious puberty at the first consultation of a pediatric endocrinologist. Before follow-up, all 20 girls were very concerned about physical differences from peers, particularly breast development. During therapy, breast regression to minimal or absent development occurred in 5/15 treated patients, who then no longer felt embarrassed about pubertal development in contrast to the other patients. Fear of sexuality remained obvious throughout the study in most patients. Feelings of loneliness and exemplary behavior were observed and tended to decrease in the treated patients and to increase in the untreated patients. Elevated scores of withdrawal, anxiety/depression and somatic complaints at Child Behavior Checklist were still observed after 2 y. These changes in behavioral and affective characteristics appeared to be related neither to height and weight, nor to development of pubic hair, which progressed in most patients. After 2 y, the physical differences remained a concern for 13 girls and the risk of short adult stature for 6. In summary, some behavioral and affective characteristics and particularities in psychosocial functioning are observed in girls with precocious puberty. During treatment with long acting triptorelin, problematic behavior and functioning decrease slightly, particularly in the few girls showing breast regression to minimal or absent development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307158     DOI: 10.1111/j.1651-2227.1997.tb08602.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  16 in total

1.  Brief Behavioral Intervention for Disruptive Behavior in a Child with a Hypothalamic Hamartoma: A Case Report.

Authors:  Rachel H Fein; Gabrielle G Banks; Marsha N Gragert; Marni E Axelrad
Journal:  J Clin Psychol Med Settings       Date:  2019-12

2.  One-Year Follow-Up of Girls with Precocious Puberty and Their Mothers: Do Psychological Assessments Change over Time or with Treatment?

Authors:  Melissa J Schoelwer; Kelly L Donahue; Paula Didrick; Erica A Eugster
Journal:  Horm Res Paediatr       Date:  2017-09-19       Impact factor: 2.852

3.  Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial.

Authors:  Lawrence A Silverman; E Kirk Neely; Gad B Kletter; Katherine Lewis; Surya Chitra; Oksana Terleckyj; Erica A Eugster
Journal:  J Clin Endocrinol Metab       Date:  2015-03-24       Impact factor: 5.958

Review 4.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Psychological assessment of mothers and their daughters at the time of diagnosis of precocious puberty.

Authors:  Melissa J Schoelwer; Kelly L Donahue; Kristina Bryk; Paula Didrick; Sheri A Berenbaum; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2015-03-16

Review 6.  Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty.

Authors:  Eun Young Kim
Journal:  Korean J Pediatr       Date:  2015-01-31

Review 7.  Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: An Indian perspective.

Authors:  Manoj Kumar; Satinath Mukhopadhyay; Deep Dutta
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

Review 8.  Pros and cons of GnRHa treatment for early puberty in girls.

Authors:  Ruben H Willemsen; Daniela Elleri; Rachel M Williams; Ken K Ong; David B Dunger
Journal:  Nat Rev Endocrinol       Date:  2014-04-08       Impact factor: 43.330

9.  Two cases of precocious puberty associated with hypothalamic hamartoma.

Authors:  Shigeru Nagaki; Eiko Otsuka; Kumiko Miwa; Makoto Funatsuka; Osami Kubo; Tomokatsu Hori; Noriyuki Shibata; Tatsuo Sawada; Makiko Osawa
Journal:  Clin Pediatr Endocrinol       Date:  2010-05-22

10.  Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty.

Authors:  Slawomir Wojniusz; Nina Callens; Stefan Sütterlin; Stein Andersson; Jean De Schepper; Inge Gies; Jesse Vanbesien; Kathleen De Waele; Sara Van Aken; Margarita Craen; Claus Vögele; Martine Cools; Ira R Haraldsen
Journal:  Front Psychol       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.